» Articles » PMID: 38806450

Crykey: Rapid Identification of SARS-CoV-2 Cryptic Mutations in Wastewater

Overview
Journal Nat Commun
Specialty Biology
Date 2024 May 28
PMID 38806450
Authors
Affiliations
Soon will be listed here.
Abstract

Wastewater surveillance for SARS-CoV-2 provides early warnings of emerging variants of concerns and can be used to screen for novel cryptic linked-read mutations, which are co-occurring single nucleotide mutations that are rare, or entirely missing, in existing SARS-CoV-2 databases. While previous approaches have focused on specific regions of the SARS-CoV-2 genome, there is a need for computational tools capable of efficiently tracking cryptic mutations across the entire genome and investigating their potential origin. We present Crykey, a tool for rapidly identifying rare linked-read mutations across the genome of SARS-CoV-2. We evaluated the utility of Crykey on over 3,000 wastewater and over 22,000 clinical samples; our findings are three-fold: i) we identify hundreds of cryptic mutations that cover the entire SARS-CoV-2 genome, ii) we track the presence of these cryptic mutations across multiple wastewater treatment plants and over three years of sampling in Houston, and iii) we find a handful of cryptic mutations in wastewater mirror cryptic mutations in clinical samples and investigate their potential to represent real cryptic lineages. In summary, Crykey enables large-scale detection of cryptic mutations in wastewater that represent potential circulating cryptic lineages, serving as a new computational tool for wastewater surveillance of SARS-CoV-2.

Citing Articles

Environmental Dissemination of SARS-CoV-2: An Analysis Employing Crassphage and Next-Generation Sequencing Protocols.

Ribeiro A, Mannarino C, Dos Santos Leal T, de Oliveira C, Bianco K, Clementino M Food Environ Virol. 2025; 17(1):13.

PMID: 39776004 DOI: 10.1007/s12560-024-09620-4.


Crykey: Rapid identification of SARS-CoV-2 cryptic mutations in wastewater.

Liu Y, Sapoval N, Gallego-Garcia P, Tomas L, Posada D, Treangen T Nat Commun. 2024; 15(1):4545.

PMID: 38806450 PMC: 11133379. DOI: 10.1038/s41467-024-48334-w.


Online dashboards for SARS-CoV-2 wastewater-based epidemiology.

Focosi D, Spezia P, Maggi F Future Microbiol. 2024; 19(9):761-769.

PMID: 38700284 PMC: 11290749. DOI: 10.2217/fmb-2024-0033.

References
1.
Siqueira J, Goes L, Alves B, de Carvalho P, Cicala C, Arthos J . SARS-CoV-2 genomic analyses in cancer patients reveal elevated intrahost genetic diversity. Virus Evol. 2021; 7(1):veab013. PMC: 7928633. DOI: 10.1093/ve/veab013. View

2.
Armero A, Berthet N, Avarre J . Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia. Viruses. 2021; 13(1). PMC: 7833370. DOI: 10.3390/v13010133. View

3.
Valesano A, Rumfelt K, Dimcheff D, Blair C, Fitzsimmons W, Petrie J . Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. PLoS Pathog. 2021; 17(4):e1009499. PMC: 8055005. DOI: 10.1371/journal.ppat.1009499. View

4.
Dhawan M, Saied A, Mitra S, Alhumaydhi F, Emran T, Wilairatana P . Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?. Biomed Pharmacother. 2022; 154:113522. PMC: 9376347. DOI: 10.1016/j.biopha.2022.113522. View

5.
Amman F, Markt R, Endler L, Hupfauf S, Agerer B, Schedl A . Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale. Nat Biotechnol. 2022; 40(12):1814-1822. DOI: 10.1038/s41587-022-01387-y. View